Nuveen, LLC Neurocrine Biosciences Inc Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Nuveen, LLC holds 286,496 shares of NBIX stock, worth $34.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
286,496Holding current value
$34.5 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
645Shares Held
95.7MCall Options Held
312KPut Options Held
311K-
Black Rock Inc. New York, NY14.2MShares$1.71 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.2 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$589 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$363 Million0.26% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$322 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.5B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...